These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 36041750)
1. Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension. Humbert M; McLaughlin V; Gibbs JSR; Gomberg-Maitland M; Hoeper MM; Preston IR; Souza R; Waxman AB; Ghofrani HA; Escribano Subias P; Feldman J; Meyer G; Montani D; Olsson KM; Manimaran S; de Oliveira Pena J; Badesch DB Eur Respir J; 2023 Jan; 61(1):. PubMed ID: 36041750 [TBL] [Abstract][Full Text] [Related]
2. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. Hoeper MM; Badesch DB; Ghofrani HA; Gibbs JSR; Gomberg-Maitland M; McLaughlin VV; Preston IR; Souza R; Waxman AB; Grünig E; Kopeć G; Meyer G; Olsson KM; Rosenkranz S; Xu Y; Miller B; Fowler M; Butler J; Koglin J; de Oliveira Pena J; Humbert M; N Engl J Med; 2023 Apr; 388(16):1478-1490. PubMed ID: 36877098 [TBL] [Abstract][Full Text] [Related]
3. Sotatercept for the Treatment of Pulmonary Arterial Hypertension. Humbert M; McLaughlin V; Gibbs JSR; Gomberg-Maitland M; Hoeper MM; Preston IR; Souza R; Waxman A; Escribano Subias P; Feldman J; Meyer G; Montani D; Olsson KM; Manimaran S; Barnes J; Linde PG; de Oliveira Pena J; Badesch DB; N Engl J Med; 2021 Apr; 384(13):1204-1215. PubMed ID: 33789009 [TBL] [Abstract][Full Text] [Related]
4. Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension. Barberà J; Jansa P; Klings E; Ristić A; Keogh A; Solum D; Rao Y; Grover R; Saib I; Sood N Adv Ther; 2024 Mar; 41(3):1062-1074. PubMed ID: 38198043 [TBL] [Abstract][Full Text] [Related]
5. Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension. Wirostko BM; Tressler C; Hwang LJ; Burgess G; Laties AM BMJ; 2012 Feb; 344():e554. PubMed ID: 22354598 [TBL] [Abstract][Full Text] [Related]
6. Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial. Sitbon O; Bosch J; Cottreel E; Csonka D; de Groote P; Hoeper MM; Kim NH; Martin N; Savale L; Krowka M Lancet Respir Med; 2019 Jul; 7(7):594-604. PubMed ID: 31178422 [TBL] [Abstract][Full Text] [Related]
7. SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension. Waxman AB; Systrom DM; Manimaran S; de Oliveira Pena J; Lu J; Rischard FP Circ Heart Fail; 2024 May; 17(5):e011227. PubMed ID: 38572639 [TBL] [Abstract][Full Text] [Related]
8. The Impact of Immunogenicity on the Pharmacokinetics, Efficacy, and Safety of Sotatercept in a Phase III Study of Pulmonary Arterial Hypertension. Liao K; Mackenzie H; Ait-Oudhia S; Manimaran S; Zeng Y; Akers T; Yun T; de Oliveira Pena J Clin Pharmacol Ther; 2024 Mar; 115(3):478-487. PubMed ID: 38012534 [TBL] [Abstract][Full Text] [Related]
9. Is sotatercept, which traps activins and growth differentiation factors, a new dawn in treating pulmonary arterial hypertension (PAH)? Doggrell SA Expert Opin Biol Ther; 2023; 23(7):589-593. PubMed ID: 37269300 [TBL] [Abstract][Full Text] [Related]
10. Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study. Raghu G; van den Blink B; Hamblin MJ; Brown AW; Golden JA; Ho LA; Wijsenbeek MS; Vasakova M; Pesci A; Antin-Ozerkis DE; Meyer KC; Kreuter M; Moran D; Santin-Janin H; Aubin F; Mulder GJ; Gupta R; Richeldi L Lancet Respir Med; 2019 Aug; 7(8):657-664. PubMed ID: 31122893 [TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial. Wolinsky JS; Arnold DL; Brochet B; Hartung HP; Montalban X; Naismith RT; Manfrini M; Overell J; Koendgen H; Sauter A; Bennett I; Hubeaux S; Kappos L; Hauser SL Lancet Neurol; 2020 Dec; 19(12):998-1009. PubMed ID: 33129442 [TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
18. Sotatercept for pulmonary arterial hypertension: something old and something new. Rubin LJ; Naeije R Eur Respir J; 2023 Jan; 61(1):. PubMed ID: 36609525 [No Abstract] [Full Text] [Related]
19. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Galiè N; Rubin Lj; Hoeper M; Jansa P; Al-Hiti H; Meyer G; Chiossi E; Kusic-Pajic A; Simonneau G Lancet; 2008 Jun; 371(9630):2093-100. PubMed ID: 18572079 [TBL] [Abstract][Full Text] [Related]